Page last updated: 2024-08-25

sofosbuvir and carbamazepine

sofosbuvir has been researched along with carbamazepine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Burger, DM; D'avolio, A; de Kanter, CT; Di Perri, G; Smolders, EJ; van 't Veer, N; van Wijngaarden, P	1
Kearney, BP; Kirby, BJ; Ling, J; Lutz, JD; Massetto, B; Mathias, A; Song, Q; Wang, L; Worth, A	1
Cole, JL; Stark, JE	1

Trials

1 trial(s) available for sofosbuvir and carbamazepine

Article	Year
Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:6 Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Carbamazepine; Computer Simulation; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inducers; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Female; Healthy Volunteers; Humans; Male; Membrane Transport Modulators; Middle Aged; Models, Biological; Organic Anion Transporters; Pregnane X Receptor; Rifabutin; Rifampin; Risk Assessment; Sofosbuvir; Substrate Specificity; Young Adult	2018

Article

Year

Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine.

Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:6

Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Carbamazepine; Computer Simulation; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inducers; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Female; Healthy Volunteers; Humans; Male; Membrane Transport Modulators; Middle Aged; Models, Biological; Organic Anion Transporters; Pregnane X Receptor; Rifabutin; Rifampin; Risk Assessment; Sofosbuvir; Substrate Specificity; Young Adult

2018

Other Studies

2 other study(ies) available for sofosbuvir and carbamazepine

Article	Year
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine. International journal of antimicrobial agents, 2016, Volume: 48, Issue:3 Topics: Anticonvulsants; Antiviral Agents; Carbamates; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Oxcarbazepine; Pyrrolidines; Sofosbuvir; Treatment Outcome; Valine	2016
Deinduction of P-glycoprotein resulting in delayed viral response during hepatitis C treatment. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:5 Topics: Anti-Retroviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Carbamazepine; Cell Membrane; Drug Combinations; Drug Interactions; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir	2021

Article

Year

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine.

International journal of antimicrobial agents, 2016, Volume: 48, Issue:3

Topics: Anticonvulsants; Antiviral Agents; Carbamates; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Oxcarbazepine; Pyrrolidines; Sofosbuvir; Treatment Outcome; Valine

2016

Deinduction of P-glycoprotein resulting in delayed viral response during hepatitis C treatment.

Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:5

Topics: Anti-Retroviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Carbamazepine; Cell Membrane; Drug Combinations; Drug Interactions; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir

2021